Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma

Current Opinion in Rheumatology

Volumn 9, Issue 6, 1997, Pages 538-543

  Rosen, Antony ^a   Casciola Rosen, Livia ^a   Wigley, Fredrick ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; FIBRILLARIN; FREE RADICAL; METAL; REACTIVE OXYGEN METABOLITE;

AUTOIMMUNITY; DISEASE PREDISPOSITION; ETIOLOGY; HUMAN; ISCHEMIA; NUCLEOLUS; OXIDATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REPERFUSION; REVIEW; SCLERODERMA;

EID: 0030734353     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199711000-00010     Document Type: Review

References (62)

1. Radic MZ, Weigert M: Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994, 12:487-520.
2. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992, 10:731-757.
3. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993, 11:729-766.
4. Lanzavecchia A: How can cryptic epitopes trigger autoimmunity? J Exp Med 1995, 181:1945-1948.
5. Gammon G, Sercarz EE: How some T cells escape tolerance induction. Nature 1989, 342:183-185.
6. Mamula MJ: The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J Exp Med 1993, 177:567-571.
7. Bockenstedt LK, Gee RJ, Mamula MJ: Self-peptides in the initiation of lupus autoimmunity. J Immunol 1995, 154:3516-3524.
8. Salemi S, Caporossi AP, Boffa L, Longobardi MG, Barnaba V: HIVgp120 activates autoreactlve CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J Exp Med 1995, 181:2253-2257.
9. Watts C, Lanzavecchia A: Suppressive effect of an antibody on processing of T cell epitopes. J Exp Med 1993, 178:1459-1463.
10. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995, 181:1957-1963.
11. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
12. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A: Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994, 269:30757-30760.
13. Casciola-Rosen LA, Anhalt GJ, Rosen A: DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995, 182:1625-1634.
14. Casciola-Rosen LA, Nicholson DW, Chong T, Rowan KR, Thomberry NA, Miller DK, Rosen A: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996, 183:1957-1964.
15. Greidinger EL, Miller DK, Yamin T, Casciola-Rosen L, Rosen A: Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett 1996, 390:299-303.
16. Casiano CA, Martin SJ, Green DR, Tan EM: Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1997, 184:765-770.
17. Casciola-Rosen L, Wigley F, Rosen A: Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997, 185:71-79. This paper demonstrates that the autoantigens targeted in diffuse scleroderma are unified by their enrichment in nucleolini and by their susceptibility to fragmentation in a novel metal-catalyzed oxidation reaction.
18. Belch JJF: Raynaud's phenomenon: its relevance to scleroderma. Ann Rheum Dis 1991, 50:839-845.
19. Norton WL, Nardo JM: Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970, 73:317-324.
20. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163.
21. Zweir JL: Measurement of superoxide-derived free radicals in the reperfused heart. J Biol Chem 1988, 263:1353-1357.
22. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA: Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A 1990, 87:5144-5147.
23. Stein CM, Tanner SB, Awad JA, Roberts LJI, Morrow JD: Evidence for free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996, 37:1146-1150. This paper presents evidence for free radical-mediated injury in scleroderma, by quantifying urinary prostanoid metabolites produced in a noncyclooxygenase, free radical-mediated reaction.
24. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV: Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 1994, 21:1477-1483.
25. Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press; 1985.
26. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc Natl Acad Sci U S A 1990, 87:9383-9387.
27. Roberts LJ, Morrow JD: Isoprostanes: novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann N Y Acad Sci 1993, 744:233-242.
28. 2-isoprostane) metabolites in human plasma and urine. J Biol Chem 1993, 268:4161-4169.
29. Herrick A, Worthington H, Rieley F, Clarke D, Schofield D, Braganza J, Jayson M: Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol 1996, 23:650-653. This paper suggests that reduced blood levels of the water-soluble antioxidants selenium and ascorbic acid in patients with scleroderma are not due to dietary deficiency and that other explanations must be sought.
30. Rosen A, Casciola-Rosen LA, Aheam J: Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995, 181:1557-1561.
31. Casciola-Rosen LA, Rosen A, Petri M, Schlissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in SLE Proc Natl Acad Sci U S A 1996, 93:1624-1629.
32. Casciola-Rosen L, Rosen A: Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production In LE. Lupus 1997, 6:175-180.
33. Rothfield NF: Autoantibodles in scleroderma. Rheum Dis Clin North Am 1992, 18:483-498.
34. Shero JH, Bordwell B, Rothfield NF, Earnshaw WC: High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 1986, 231:737-740.
35. Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA: Anti-NOR 90: a new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol 1987, 139:2579-2584.
36. Hirakata M, Okano Y, Suwa A, Medsger TA Jr, Hardin JA, Craft J: Identification of autoantibodies to RNA polymerase II: occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. J Clin Invest 1993, 91:2665-2672.
37. Aris JP, Blobel G: cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera. Proc Natl Acad Sci U S A 1991, 88:931-935.
38. Tan EM: Autoantibodies in pathology and cell biology. Cell 1991, 67:841-842.
39. Cajal SR: Histology, edn 10. Baltimore: William Wood; 1933.
40. Mager M, McNary WF, Lionetti F: The histochemical detection of zinc. J Histochem Cytochem 1953, 1:493-504.
41. Studzinski GP: Selective binding of zinc by basic proteins of the HeLa cell nucleolus. J Histochem Cytochem 1965, 13:365-375.
42. Studzinski GP, Reidbord HE, Love R: Enhancement of the affinity of nucleoli and chromosomes for zinc by treatment with chromic acid. Stain Technol 1967, 42:301-306.
43. Studzinski GP, Love R: Nucleolar organelles shown by lead precipitation in unfixed cultured cells. Stain Technol 1964, 39:397-401.
44. Ochs RL, Busch H: Further evidence that phosphoprotein C23 (110kD/pl 5.1) is the nucleolar silver staining protein. Exp Cell Res 1984, 152:260-265.
45. Libanati CM, Tandler CJ: The distribution of the water soluble inorganic orthophosphate ions within the cell: accumulation in the nucleus. J Cell Biol 1969, 42:754-765.
46. Tandler CJ: The detection of orthophosphate within the cell nucleus. Exp Cell Res 1961, 25:246-250.
47. Tandler CJ: The localization of intracellular orthophosphate: the role of the nucleoli. Biochim Biophys Acta 1960, 44:536-542.
48. Tandler CJ: An acid-soluble component of the nucleolus: the cytochemical specificity of the "lead-acetate reaction." J Histochem Cytochem 1956, 4:331-340.
49. Tandler CJ, Solari AJ: Nucleolar orthophosphate ions: electron microscope and diffraction studies. J Cell Biol 1969, 41:91-108.
50. Fucci L, Oliver CN, Coon MJ, Stadtman ER: Inactivation of key metabolic enzymes by mixed function oxidation reactions: possible implications in protein turnover and ageing. Proc Natl Acad Sci U S A 1983, 80:1521-1525.
51. Davies KJA: Protein damage and degradation by oxygen radicals: I. general aspects. J Biol Chem 1987, 262:9895-9901.
52. Levine RL, Oliver CN, Fulks RM, Stadtman ER: Turnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysis. Proc Natl Acad Sci U S A 1981, 78:2120-2124.
53. Stadtman ER: Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 1990, 9:315-325.
54. Rana TM, Meares CF: Specific cleavage of a protein by an attached iron chelate. J Am Chem Soc 1990, 112:2457-2458.
55. Wu J, Perrin DM, Sigman DS, Kaback HR: Helix packing of lactose permease in Escherichia coli studies by site-directed chemical cleavage. Proc Natl Acad Sci U S A 1995, 92:9186-9190.
56. Rana TM, Meares CF: Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proc Natl Acad Sci U S A 1991, 88:10578-10582.
57. Lima CD, Wang JC, Mondragon A: Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I. Nature 1994, 367:138-146.
58. Treich I, Riva M, Sentenac A: Zinc-binding subunits of yeast RNA polymerases. J Biol Chem 1991, 266:21971-21976.
59. Brendel V, Dohlman J, Blaisdell BE, Karlin S: Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci U S A 1991, 88:1536-1540.
60. Pollard KM, Lee DK, Casiano CA, Bluther M, Johnston MM, Tan EM: The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 1997, 158:3521-3528. This paper demonstrates that the structure of fibrillarin is directly modified by mercury salts, possibly altering its immunogenicity.
61. Griem P, Gleichmann E: Metal Ion induced autoimmunity. Curr Opin Immunol 1995, 7:831-838.
62. Kuwana M, Medsger TA Jr, Wright TM: T cell proliferate response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest 1995, 96:586-596.